CNA Financial’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,192
| Closed | -$197K | – | 161 |
|
|
2022
Q3 | $197K | Sell |
10,192
-3,500
| -26% | -$67.7K | 0.07% | 162 |
|
|
2022
Q2 | $349K | Sell |
13,692
-1,850
| -12% | -$47.2K | 0.12% | 152 |
|
|
2022
Q1 | $400K | Buy |
15,542
+1,790
| +13% | +$46.1K | 0.12% | 160 |
|
|
2021
Q4 | $576K | Buy |
13,752
+1,760
| +15% | +$73.7K | 0.15% | 149 |
|
|
2021
Q3 | $522K | Buy |
11,992
+50
| +0.4% | +$2.18K | 0.14% | 156 |
|
|
2021
Q2 | $565K | Buy |
11,942
+1,070
| +10% | +$50.6K | 0.16% | 153 |
|
|
2021
Q1 | $557K | Sell |
10,872
-6,880
| -39% | -$352K | 0.17% | 152 |
|
|
2020
Q4 | $475K | Buy |
17,752
+5,520
| +45% | +$148K | 0.15% | 164 |
|
|
2020
Q3 | $420K | Buy |
12,232
+1,300
| +12% | +$44.6K | 0.15% | 147 |
|
|
2020
Q2 | $448K | Buy |
+10,932
| New | +$448K | 0.18% | 133 |
|